Study of the Impact of Freezing-thawing Procedures and the Prolonged Culture of Embryos on Epigenetic Regulation in Humans
NCT ID: NCT02171884
Last Updated: 2024-03-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
298 participants
OBSERVATIONAL
2013-01-17
2022-05-02
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Participation consists in accepting samples to be taken at the birth of the infant:
1. from the umbilical cord.
2. from the placenta.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Embryologist's Impact on Blastocyst Vitrification and Thawing
NCT06220227
Comparing Pregnancy Outcomes in Good Prognosis Patients Between Fresh and 'Freeze-All' Single Blastocyst Transfers
NCT02712840
Comparison of Thawing Embryos in Advance and on the Day of Transfer on Pregnancy Outcomes in FET Cycle
NCT04455191
Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)
NCT00702273
Optimization of Frozen Embryo Transfers by Studying Progesterone on the Day of Transfer
NCT04290520
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group E1
Singletons born following ART via IVF/ICSI (short culture)
Sample of cord blood
Sample of placenta
Group EC1
Singletons born following ART via IVF/ICSI and freezing-thawing of the embryo
Sample of cord blood
Sample of placenta
Group T1
Singletons conceived naturally
Sample of cord blood
Sample of placenta
Group E2
Singletons born following ART with IVF/ICSI (prolonged culture)
Sample of cord blood
Sample of placenta
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Sample of cord blood
Sample of placenta
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with national health insurance cover,
* Maternal age at conception between 20 and 43 years,
* Paternal age at conception between 18 and 50 years,
* Singleton pregnancy
Exclusion Criteria
* pulmonary, cardiac
* renal and metabolic diseases (including type 1 and 2 diabetes prior to the pregnancy)
* systemic inflammatory diseases
* hypertension
* neurological diseases
* chronic hepatitis B or C
* HIV infection
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
CHU de BESANCON
Besançon, , France
CHU de DIJON
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAUQUE DB 2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.